Suppr超能文献

动脉高血压患者循环中瘦素水平升高:与动静脉瘦素溢出及摄取的关系。

Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin.

作者信息

Henriksen J H, Holst J J, Moller S, Andersen U B, Bendtsen F, Jensen G

机构信息

Department of Clinical Physiology, Hvidovre Hospital, University of Copenhagen, DK-2650 Hvidovre, Denmark. jens.h,

出版信息

Clin Sci (Lond). 2000 Dec;99(6):527-34.

Abstract

Leptin, a peptide hormone produced mainly in fat cells, appears to be important for the regulation of metabolism, insulin secretion/sensitivity and body weight. Recently, elevated plasma leptin levels have been reported in patients with arterial hypertension. Because a change in circulating leptin concentrations in such patients could be caused by altered rates of production or disposal, or both, the aim of the present study was to identify regions of leptin overflow into the bloodstream and of leptin extraction. Patients with arterial hypertension (n=12) and normotensive controls (n=20) were studied during catheterization with elective blood sampling from different vascular beds (artery, and renal, hepatic, iliac and cubital veins). Plasma leptin was determined by a radioimmunoassay. Patients with hypertension had significantly elevated levels of circulating leptin (12.8 ng/l, compared with 4.1 ng/l in the controls; P<0.001), and this was also the case when adjusted for body mass index (BMI) [0.435 and 0.167 ng/l per unit BMI (kg/m(2)) respectively; P<0.001]. Circulating leptin was directly related to arterial blood pressure (r=0.38-0.62, P</=0.05-0.005) and immunoreactive insulin (r=0.51, P<0.62), but not to plasma renin activity. A significant renal extraction ratio for leptin was seen in the hypertensive patients, but this was not significantly lower than that in the controls (0.09 compared with 0. 16; P=0.1). The hypertensive patients had a significantly higher hepatic venous/arterial leptin ratio than the controls (1.02 compared with 0.93; P<0.02), and this ratio was correlated directly with the BMI (r=0.38, P=0.05) and immunoreactive insulin (r=0.43, P<0.05). In both hypertensive patients and controls there was a significant spillover of leptin into the iliac vein, but not into the cubital vein. In conclusion, the high concentration of circulating leptin in patients with arterial hypertension is probably caused by increased release of leptin from abdominal (especially mesenteric and omental) and gluteal adipose tissue stores, and renal extraction is slightly reduced. Leptin kinetics in arterial hypertension require further investigation.

摘要

瘦素是一种主要在脂肪细胞中产生的肽类激素,似乎对新陈代谢、胰岛素分泌/敏感性及体重的调节很重要。最近,有报道称动脉高血压患者的血浆瘦素水平升高。由于此类患者循环中瘦素浓度的变化可能是由生成或清除速率改变,或两者兼而有之引起的,本研究的目的是确定瘦素溢入血流的部位及瘦素的摄取情况。在对动脉高血压患者(n = 12)和血压正常的对照者(n = 20)进行导管插入术期间,从不同血管床(动脉、肾静脉、肝静脉、髂静脉和肘静脉)进行选择性采血。采用放射免疫分析法测定血浆瘦素。高血压患者的循环瘦素水平显著升高(12.8 ng/l,而对照组为4.1 ng/l;P < 0.001),调整体重指数(BMI)后也是如此[分别为每单位BMI(kg/m²)0.435和0.167 ng/l;P < 0.001]。循环瘦素与动脉血压直接相关(r = 0.38 - 0.62,P≤0.05 - 0.005)及免疫反应性胰岛素相关(r = 0.51,P < 0.62),但与血浆肾素活性无关。高血压患者的瘦素肾摄取率显著,但并不显著低于对照组(分别为0.09和0.16;P = 0.1)。高血压患者的肝静脉/动脉瘦素比值显著高于对照组(分别为1.02和0.93;P < 0.02),且该比值与BMI直接相关(r = 0.38,P = 0.05)及免疫反应性胰岛素相关(r = 0.43,P < 0.05)。在高血压患者和对照组中,瘦素均显著溢入髂静脉,但未溢入肘静脉。总之,动脉高血压患者循环中瘦素浓度高可能是由于腹部(尤其是肠系膜和网膜)及臀脂肪组织储存中瘦素释放增加所致,且肾摄取略有减少。动脉高血压中的瘦素动力学需要进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验